GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » Cash Flow from Financing

Response Oncology (Response Oncology) Cash Flow from Financing : $-4.5 Mil (TTM As of Mar. 2002)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2002, Response Oncology paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $1.4 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.0 Mil on other financial activities. In all, Response Oncology spent $1.4 Mil on financial activities for the three months ended in Mar. 2002.


Response Oncology Cash Flow from Financing Historical Data

The historical data trend for Response Oncology's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology Cash Flow from Financing Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.30 -1.40 -5.94 -4.43 -8.52

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.42 -0.07 -0.05 -2.99 -1.36

Response Oncology Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Response Oncology's Cash from Financing for the fiscal year that ended in Dec. 2001 is calculated as:

Response Oncology's Cash from Financing for the quarter that ended in Mar. 2002 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology  (GREY:ROIX) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Response Oncology's issuance of stock for the three months ended in Mar. 2002 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Response Oncology's repurchase of stock for the three months ended in Mar. 2002 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Response Oncology's net issuance of debt for the three months ended in Mar. 2002 was $-1.4 Mil. Response Oncology spent $1.4 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Response Oncology's net issuance of preferred for the three months ended in Mar. 2002 was $0.0 Mil. Response Oncology paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Response Oncology's cash flow for dividends for the three months ended in Mar. 2002 was $0.0 Mil. Response Oncology received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Response Oncology's other financing for the three months ended in Mar. 2002 was $0.0 Mil. Response Oncology received $0.0 Mil on other financial activities.


Response Oncology Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Response Oncology's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines